Market Overview

Syneron Settles US Patent Infringement Suit with EndyMed, Eclipse Aesthetics

Related ELOS
ABIOMED Up on License from Opsens - Analyst Blog
Balanced Outlook on Accuray - Analyst Blog

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products. EndyMed and its United States distributor, Eclipse Aesthetics, agreed to immediately stop selling EndyMed's Fractional Skin Resurfacing Products in the United States but may continue to service and support previously purchased products and supply replacement electrodes for them.

Posted-In: News Legal

 

Related Articles (ELOS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters